Featured News

The Celiac Disease Foundation achieved a number of critical milestones in 2020 in our efforts to accelerate the development of treatments and a cure for celiac disease.

Dietitians and doctors say a new federal bill to extend Medicare coverage for nutritional therapy provided by a registered dietitian would provide better healthcare for Americans with celiac disease.

I want to share with you an update of our work in Washington, DC with Congress and NIH to accelerate research for diagnostics, treatments, and a cure for celiac disease.

Camp Celiac's campers, counselors, and junior counselors will eat delicious gluten-free food and enjoy traditional camp activities such as a ropes course, rock climbing, zip-lining, swimming, archery, arts and crafts, talent share, skit night, and outdoor sports. Three meals a day without having to ask if any of the foods are gluten free is life changing for many campers and staff!

Thanks to your generous support, we are deploying iCureCeliac and iQualifyCeliac, as well as other assets unique to the Foundation, to further celiac disease drug development.

CDF has been approved for a $100,000 funding award through the Eugene Washington PCORI Engagement Awards program. The funds will support the community convening of patient advocates, researchers, and other key stakeholders to create a roadmap for patient advocate engagement in research.

Confronted with the reality of an all-consuming global pandemic, every nonprofit, including the Celiac Disease Foundation, has to figure out where we fit in a world that is quickly changing and into a future that no one can predict.

The first mice with characteristics of celiac disease have been developed at the University of Chicago Celiac Disease Center. For the first time researchers can observe celiac disease onset as the mouse’s immune system launches a coordinated attack against gluten.

The Celiac Disease Foundation uses peer-reviewed research to push our federal government to act responsibly. Our sponsorship of Columbia University’s Biennial Symposium, where the world’s expert celiac researchers share their findings and collaborate on future projects, continues this work.

Dr. Dan Leffler, Celiac Disease Foundation Medical Advisory Board Member and clinician and researcher at Harvard Medical School and Takeda, spoke about the profound ineffectiveness and failure of the gluten-free diet as a treatment for celiac disease.